Neonc Technologies Holdings NTHI
NASDAQ NTHI
$4.68 +0.12 (+2.52%)
At close: Aug 21, 2026 · 4:00 PM EDT

Neonc Technologies Holdings (NTHI) Liabilities and Shareholders Equity (2024 - 2026)

Neonc Technologies Holdings (NTHI) posted quarterly Liabilities and Shareholders Equity of $3.3 million for Q1 2026, down 60.55% year-over-year from $8.4 million in Q1 2025, and up 17.94% quarter-over-quarter from $2.8 million in Q4 2025.

Neonc Technologies Holdings (NTHI) Liabilities and Shareholders Equity (2024 - 2026) Analysis & Trends

Neonc Technologies Holdings (NTHI) has reported Liabilities and Shareholders Equity for 3 consecutive years, with $3.3 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity fell 60.55% year-over-year to $3.3 million; the TTM figure through Mar 2026 stood at $13.2 million (up 11.52% YoY), while the FY2025 annual figure was $2.8 million, down 17.37% from the prior year.
  • Liabilities and Shareholders Equity advanced to $3.3 million in Q1 2026 per NTHI's latest filing, from $2.8 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $8.4 million in Q1 2025 and bottomed at $2.8 million in Q4 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $4.2 million across 3 years, with a median of $3.4 million in 2024.
  • Annual changes were most pronounced in 2025 — Liabilities and Shareholders Equity retreated 17.37% — and 2026, when it slumped 60.55%.
  • Neonc Technologies Holdings' Liabilities and Shareholders Equity stood at $3.4 million in 2024, then decreased by 17.37% to $2.8 million in 2025, then gained by 17.94% to $3.3 million in 2026.
  • Business Quant data shows NTHI's Liabilities and Shareholders Equity at $3.3 million in Q1 2026, $2.8 million in Q4 2025, and $4.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 27.42 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 41.73 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 10.03 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 10.96 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 9.18 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 5.56 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 25.60 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 2.10 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 19.82 Bn
10 Neonc Technologies Holdings 116.41 Mn 116.41 Mn - 5.23 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 5.23 Mn
Mar 31, 2026 3.33 Mn
Dec 31, 2025 2.82 Mn
Sep 30, 2025 4.08 Mn
Jun 30, 2025 2.99 Mn
Mar 31, 2025 8.44 Mn
Dec 31, 2024 3.42 Mn